Delivery Order SPE2DB20D2014-SPE2DB25FC55L
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injectors valued at $12,590.49. This non-competitive, firm fixed-price delivery order is expected to be completed by August 19, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Trulicity 3 mg/0.5 ml pen injectors valued at $1,792.32. This is a firm fixed price delivery order with an ultimate completion date of August 7, 2025, executed without a set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order as a child delivery order under its larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Trulicity 3 mg/0.5 ml pen injectors valued at $1,651.65. This firm fixed-price delivery order, with an ultimate completion date of August 8, 2025, represents a competitive award with no set-aside designation. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors, with a contract ceiling value of $1,380.46 and an ultimate completion date of July 15, 2025. This is a firm fixed-price, non-set-aside delivery order reflecting a routine pharmaceutical procurement under the company's existing contract vehicle. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors valued at $1,435.89. This is a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and represents a non-set-aside competitive award. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections with a ceiling value of $2,252.25. This non-competitive delivery order, utilizing firm fixed pricing, represents a discrete pharmaceutical procurement under AmerisourceBergen's broader relationship with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors, with a ceiling value of $1,801.80 and an ultimate completion date of September 16, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors valued at $1,801.80. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The contract is scheduled for ultimate completion on August 29, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,504.50 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pen injectors on July 22, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by July 23, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $3,419.13 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors (0.5 ml). This firm fixed-price delivery order, with an ultimate completion date of June 20, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The award carries no set-aside designation and reflects...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC55LDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Trulicity 3 mg/0.5 ml pen injectors valued at $1,501.50. This firm fixed price delivery order represents a non-set-aside competitive award and is scheduled for completion by July 25, 2025, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, with an extensive portfolio of brand-name and generic medications across multiple therapeutic domains. This delivery order for Trulicity, a diabetes management medication, exemplifies the company's role in supporting the Defense Health Agency and other federal healthcare customers through the DLA's comprehensive medical supply chain. The contract reflects AmerisourceBergen's demonstrated capability to fulfill federal procurement requirements in open competition, with its IDC vehicle enabling flexible pharmaceutical sourcing to meet military healthcare needs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 7/24/25 |